Your Window Into the Innovation Economy

This curated selection of 100 ventures from AV’s portfolio of over 1,600+ current and historical investments represents the names our 10 venture teams are most excited to spotlight. These companies were selected for their variety, innovative impact, performance, and upside potential.

Alumni Ventures is one of the world’s most active venture capital firms, backing trailblazing companies that are reshaping industries and defining the future. Over the past decade, we’ve invested in breakthroughs across AI, biotechnology, quantum computing, and next-generation manufacturing — domains that push the boundaries of what’s possible. Today, we’re excited to introduce the AV Deep Tech 10 — a curated selection of 10 game-changing portfolio companies at the forefront of deep tech innovation.

At Alumni Ventures, we invest in the builders shaping the next generation of transformative technology. When we first evaluated Cohere, we weren’t just looking at growth metrics — we were examining a differentiated approach in one of the most competitive markets in tech. This is the story of why we backed a company that’s quietly become one of the fastest-growing names in AI.

In 1928, Sir Alexander Fleming returned from vacation to find that a petri dish of Staphylococcus cultures had been contaminated — an accident that led to the discovery of penicillin. Ninety years later, in 2018, Japanese scientists accidentally altered an enzyme and found it could break down plastic significantly faster. What connects these seemingly unrelated moments isn’t meticulous adherence to the scientific method. These “happy accidents” weren’t born from controlled, procedural experimentation. Instead, they reflect how scientific breakthroughs often emerge from veering off course, driven not by protocol, but by the curiosity, intuition, and creativity that define human discovery.